Literature DB >> 20345761

Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.

Kuei-Hua Chang1, Yolanda de Pablo, Hyun-pil Lee, Hyoung-gon Lee, Mark A Smith, Kavita Shah.   

Abstract

Cyclin-dependent kinase (Cdk) 5 and p38 activities are significantly increased in Alzheimer's Disease (AD). Both p38 and Cdk5 promote neurodegeneration upon deregulation. However, to date the mechanistic link between Cdk5 and p38 remains unclear. This study presents the first mechanism showing Cdk5 as a major regulator of p38 cascade in neurons and in transgenic mouse model of AD. Using beta-amyloid and glutamate as the neurotoxic stimuli, our results show that deregulated Cdk5 induces p38 activation by increasing reactive oxygen species (ROS) in neuronal cells and in primary cortical neurons. Elimination of ROS inhibits p38 activation, revealing ROS as major stimuli of the p38 cascade. Importantly, Cdk5-mediated p38 activation increases c-Jun expression, thereby revealing a mechanistic link between deregulated Cdk5 and c-Jun level in AD brains. c-Jun is over-expressed in AD, and is believed to contribute significantly to neurodegeneration. Based on the proposed mechanism, Cdk5 inhibition is more neuroprotective relative to p38 and c-Jun, suggesting that Cdk5 is an upstream regulator of neurodegenerative pathways triggered by p38 and a preferable therapeutic target for AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345761     DOI: 10.1111/j.1471-4159.2010.06687.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

Review 1.  Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Authors:  Jaume Folch; Felix Junyent; Ester Verdaguer; Carme Auladell; Javier G Pizarro; Carlos Beas-Zarate; Mercè Pallàs; Antoni Camins
Journal:  Neurotox Res       Date:  2011-10-01       Impact factor: 3.911

2.  Neuroprotective effects of Tongmai Yizhi Decoction () against Alzheimer's disease through attenuating cyclin-dependent kinase-5 expression.

Authors:  Jing-Han Feng; Bao-Chang Cai; Wei-Feng Guo; Ming-Yan Wang; Yong Ma; Qiao-Xi Lu
Journal:  Chin J Integr Med       Date:  2016-07-09       Impact factor: 1.978

3.  Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.

Authors:  Chun Shi; Keith Viccaro; Hyoung-Gon Lee; Kavita Shah
Journal:  J Cell Sci       Date:  2016-03-09       Impact factor: 5.285

Review 4.  Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.

Authors:  Kavita Shah; Sandra Rossie
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

Review 5.  Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Authors:  Varsha Shukla; Susan Skuntz; Harish C Pant
Journal:  Arch Med Res       Date:  2012-11-07       Impact factor: 2.235

6.  The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.

Authors:  Kumar Nikhil; Kavita Shah
Journal:  J Cell Sci       Date:  2017-07-27       Impact factor: 5.285

7.  Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.

Authors:  Kumar Nikhil; Keith Viccaro; Kavita Shah
Journal:  Mol Neurobiol       Date:  2018-06-08       Impact factor: 5.590

8.  DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease?

Authors:  Jyotshna Kanungo
Journal:  Brain Disord Ther       Date:  2017-05-01

Review 9.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 10.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.